$312.41
0.100.03%
At close: Apr 22, 5:00 PM EST
$312.41
N/A
After Hours: 4:00 PM EST
BeOne Medicines Ltd Earnings Estimates
ONCNASDAQ
Earnings: Q1 2026 Earnings in 13 days from now on Wed May 6th, before the market open
BeOne Medicines Earnings Estimates, EPS & Revenue | NASDAQ:ONC
BeOne Medicines (ONC) is scheduled to report Q1 earnings on May 6, 2026. Analysts estimate EPS of $0.87 and quarterly revenue of $1.45B.
In the most recent quarter (Q4), BeOne Medicines reported EPS of $1.95, beating estimates of $1.42 by 0.37%. Revenue came in at $1.50B, exceeding the estimate of $1.45B by 0.03%.
BeOne Medicines has beaten EPS estimates in 4 consecutive quarters.
Over the last 4 quarters, BeOne Medicines has averaged an EPS surprise of 2.69% and a revenue surprise of 0.04%.
Earnings Date
May 6
EPS Estimate
$0.870
Quarterly Revenue Estimate
$1.45B
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$5.34B
BeOne Medicines Earnings History
Analyze the earnings history of BeOne Medicines using advanced sorting and filters.
Loading calendar...
BeOne Medicines (ONC) Earnings Per Share
The chart below shows BeOne Medicines's reported EPS compared to analyst estimates over recent quarters.
BeOne Medicines (ONC) Revenue
The chart below shows BeOne Medicines's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is BeOne Medicines (NASDAQ:ONC) reporting earnings?
BeOne Medicines (ONC) is scheduled to report earnings on May 6, 2026. The last reported earnings were for reported on February 26, 2026 for Q4.
What were the latest earnings per share (EPS) for BeOne Medicines (NASDAQ:ONC)?
The Actual EPS was $1.95, which beat the estimate of $1.42.
What were BeOne Medicines’s (NASDAQ:ONC) revenues?
The Actual Revenue was $1.50B, which beat the estimate of $1.45B.
